Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q2 2014 · 10-Q
Revenue$0.00$0.00no prior Q2 2013 on file Net Income-$563.99K-$563.99KN/M vs Q2 2013 EPS Diluted$0.00$0.00— vs Q2 2013 Operating Income-$545,705N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
ended Jun 30, 2014 · filed Aug 14, 2014 · 45 d after period end